Innoviva Inc. - SCHEDULE 13G/A Filing
2026-03-27SEC Filing SCHEDULE 13G/A (0000102909-26-001591)
This filing is an amendment (Amendment No. 10) to a SCHEDULE 13G/A for Innoviva Inc. by The Vanguard Group. The filing indicates that The Vanguard Group, as an investment advisor, has no beneficial ownership of Innoviva Inc. common stock, with 0 shares owned and 0% ownership. This is a change from a previous filing where they held a significant amount of shares. The filing also notes that Vanguard subsidiaries and business divisions will now report beneficial ownership separately following an internal realignment on January 12, 2026, as per SEC Release No. 34-39538. This realignment means The Vanguard Group, Inc. no longer has beneficial ownership over securities held by these subsidiaries and divisions.
Related industry:Biotechnology
Source:Original SEC Document β